Cargando…
Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer
Whole-genome and transcriptome sequencing were used to discover novel gene fusions in a case of colon cancer. A tumor-specific LACTB2-NCOA2 fusion originating from intra-chromosomal rearrangement of chromosome 8 was identified at both DNA and RNA levels. Unlike conventional oncogenic chimeric protei...
Autores principales: | Yu, J, Wu, W K K, Liang, Q, Zhang, N, He, J, Li, X, Zhang, X, Xu, L, Chan, M T V, Ng, S S M, Sung, J J Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717154/ https://www.ncbi.nlm.nih.gov/pubmed/25823027 http://dx.doi.org/10.1038/onc.2015.72 |
Ejemplares similares
-
Identification of LACTB2, a metallo-β-lactamase protein, as a
human mitochondrial endoribonuclease
por: Levy, Shiri, et al.
Publicado: (2016) -
Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma
por: Liu, Jinlu, et al.
Publicado: (2021) -
LACTB suppresses carcinogenesis in lung cancer and regulates the EMT pathway
por: Xu, Yihui, et al.
Publicado: (2022) -
LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application
por: Li, Xiaohua, et al.
Publicado: (2022) -
Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)